[1]Morita Y, Johnson RW, Dorn RE, et al.Regional anticoagulation during hemodialysis using citrate[J].Am J Med Sci, 1961, Jul(242):32-43
[2]Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) .KDIGO Clinical Practice Guideline for Acute Kidney Injury 2012[J].Kidney Int, 2012, -(-):1-138
[3] 陈香美.血液净化标准操作规程(2020版)[J].北京：人民军医出版社, 2020, -(-):---
[4]Bauer E, Derfler K, Joukhadar C, et al.Citrate kinetics in patients receiving long-term hemodialysis therapy[J].Am J Kidney Dis, 2005, 46(5):903-907
[5]Dhondt A, Vanholder R, Tielemans C, et al.Effect of regional citrate anticoagulation on leukopenia,complement activation,and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes[J].Nephron, 2000, 85(4):334-342
[6]Gritters M, Grooteman MP, Schoorl M, et al.Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis[J].Nephrol Dial Transplant, 2006, 21(1):153-159
[7]Taki K, Takayama F, Tsuruta Y, et al.Oxidative stress,advanced glycation end product,and coronary artery calcification in hemodialysis patients[J].Kidney Int, 2006, 70(1):218-224
[8]Ahmad S, Callan R, Cole JJ, et al.Dialysate made from dry chemicals using citric acid increases dialysis dose[J].Am J Kidney Dis, 2000, 35(3):493-499
[9]Charney DI, Salmond R.Cardiac arrest after hypertonic citrate anticoagulation for chronic hemodialysis[J].ASAIO Trans., 1990, 36(3):217-219
[10]Lanckohr C, Hahnenkamp K, Boschin M.Continuous renal replacement therapy with regional citrate anticoagulation: do we really know the details?[J].Curr Opin Anaesthesiol, 2013, 26(4):428-437
[11]庄峰, 毕逍, 丁峰.长时间枸橼酸抗凝在维持性血液透析患者中的疗效观察[J].临床肾脏病杂志, 2020, 20(09):740-744
[12]Apsner R, Buchmayer H, Lang T, et al.Simplified citrate anticoagulation for high-flux hemodialysis[J].Am J Kidney Dis, 2001, 38(5):979-987
[13]Buturovic-Ponikvar J, Cerne S, Gubensek J, et al.Regional citrate anticoagulation for hemodialysis: calcium-free vscalcium containing dialysate - a randomized trial.[J].Int J Artif Organs., 2008, 31(5):418-424
[14]Evenepoel P, Maes B, Vanwalleghem J, et al.Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate[J].Am J Kidney Dis, 2002, 39(2):315-323
[15]Mahmood D, Stegmayr BG.Haemodialysis with Tinzaparin Versus Dialysate Citrate as Anticoagulation[J].Blood Purif, 2018, 46(3):257-263
[16]Lin T, Song L, Huang R, et al.Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies[J].BMC Nephrol, 2019, 20(1):472-472
[17] 叶朝阳, 付文成, 戎殳等.高浓度枸橼酸钠应用于含钙透析液行常规血液透析37例临床分析[J].中国实用内科杂志, 2005, -(04):362-363
[18] 张东亮, 张潘, 张周沧.分段枸橼酸抗凝进行含钙透析液高通量血液透析的临床观察[J].中国血液净化, 2016, -(12):686-690
[19] 杨松涛, 赵娜, 胡军, 等.应用普通含钙透析液局部枸橼酸抗凝血液透析的临床观察[J].中国血液净化, 2017, -(07):474-476
[20]雷丽静, 高菊林, 蒋红莉, 等.高出血风险患者两段法枸橼酸抗凝血液透析的临床观察[J].川北医学院学报, 2019, 34(05):593-596
[21]朱淑华, 樊蓉, 徐斌, 等.简化枸橼酸抗凝无肝素透析的疗效观察[J].肾脏病与透析肾移植杂志, 2017, 26(04):323-327
[22]Kreuzer M, Bonzel KE, Büscher R, et al.Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding[J].Nephrol Dial Transplant, 2010, 25(10):3337-3342
[23] 冉梦晓, 陈辉.局部枸橼酸抗凝对老年终末期肾脏病维持性血液透析患者肾功能、凝血功能及体外循环凝血的影响分析[J].中国医学前沿杂志(电子版), 2019, -(04):49-52
[24]Kiki? Z, Lorenz M, Sunder-Plassmann G, et al.Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials[J].Transplantation, 2009, 88(12):1377-1385
[25]Patel S, Wendon J.Regional citrate anticoagulation in patients with liver failure--time for a rethink?[J].Crit Care, 2012, 16(5):153-153
[26] Pourcine F, Vong LVP, Chelly J, et al.Sustained low-efficiency dialysis with regional citrate anticoagulation for patients with liver impairment in intensive care unit: A single-center experience.[J].Ther Apher Dial, 2020, -(-):---
[27]Chen C, Ye C.Regional anticoagulation with citrate for maintenance haemodialysis in a patient with liver cirrhosis for 30 months[J].Nephrology (Carlton), 2011, 16(08):786-787
[28]Wexler IB, Pincus JB, Natelson S, et al.The fate of citrate in erythroblastotic infants treated with exchange transfusion[J].J Clin Invest, 1949, 28(3):474-481
[29]Schmitz M, Joannidis M, Czock D, et al.Regional citrate anticoagulation in renal replacement therapy in the intensive care station : Recommendations from the renal section of the DGIIN,?GIAIN and DIVI[J].Med Klin Intensivmed Notfmed, 2018, 113(5):377-383
[30]Buturovi?-Ponikvar J, Pernat AM, Ponikvar R.Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load[J].Ther Apher Dial, 2005, 9(3):258-261
[31]Antonic M, Gubensek J, Buturovic-Ponikvar J, et al.Treatment Efficacy and Safety During Plasma Exchange With Citrate Anticoagulation: A Randomized Study of 4 Versus 15% Citrate[J].Artif Organs, 2016, 40(4):368-375
[32]Farah M, Levin A, Kiaii M, et al.Combination hemodialysis and centrifugal therapeutic plasma exchange: 18 years of Canadian experience[J].Hemodial Int, 2013, 17(2):256-265
[33]Ponikvar R, Guben?ek J, Ponikvar JB.Citrate Anticoagulation in Tandem Membrane Plasma-Exchange or Immunoadsorption and Hemodialysis in Patients With Immunological Diseases and Dialysis-Dependence[J].Ther Apher Dial., 2016, 20(3):246-250
[34]Potier J, Dolley-Hitze T, Hamel D, et al.Long-term effects of citric acid-based bicarbonate haemodialysis on patient outcomes: a survival propensity score-matched study in western France[J].Nephrol Dial Transplant, 2020, 35(7):1228-1236
[35] Gabutti L, Lucchini B, Marone C, et al.Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes[J].BMC Nephrol, 2009, -(10):7-7
[36]Martin KJ, González EA.Strategies to minimize bone disease in renal failure[J].Am J Kidney Dis, 2001, 38(6):1430-1436
[37] Kuragano T, Furuta M, Yahiro M, et al.Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH[J].BMC Nephrol, 2013, -(14):18-18
[38]Apsner R, Gruber D, H?rl WH, et al.Parathyroid hormone secretion during citrate anticoagulated hemodialysis in acutely ill maintenance hemodialysis patients[J].Anesth Analg, 2004, 99(4):1199-1204
